Alsahafi, 2019 - Google Patents
Protecting HIV-1-infected cells from ADCC: Role of NefAlsahafi, 2019
View PDF- Document ID
- 16377552763638674918
- Author
- Alsahafi N
- Publication year
External Links
Snippet
Despite the enormous efforts that are being made to develop new therapeutic strategies to fight HIV-1 infection, a better understanding of the elements contributing to HIV-1 virulence remains necessary to improve the effectiveness of these therapies. Emerging evidences …
- 230000002633 protecting 0 title description 11
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70514—CD4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Alsahafi | Protecting HIV-1-infected cells from ADCC: Role of Nef | |
Powell | Genetically Modified Immune Cells Secreting Broadly Neutralizing Antibodies against HIV: Restoration of Systemic Immunity | |
Altaf | 232 Explosive Expansion of HIV and associated risk factors among Male and Hijra Sex Workers in Sindh, Pakistan | |
Yen | SIV envelope glycoprotein determinants of macrophage tropism and their relationship to neutralization sensitivity and CD4-independent cell-to-cell transmission | |
Slyker | HIV-1 Infection in Kenyan Infants: Natural History and T cell Responses | |
Fan | Humoral and Cellular Immune Response in SIV/HIV-1 Infection and Vaccination | |
Swanstrom | Dissociating Siv Env and Cd4: Consequenes for Virus and Host | |
Musich | HIV-1 R5 Tropism: Determinants, Macrophages, and Dendritic Cells: A Dissertation | |
Onigbogi | 138 Prevalence of Human Papillomavirus (HPV) Infection among HIV-positive women in the Pre-HAART and HAART era in a Nigerian Clinic | |
Subramanya | 213 Dendritic cell-specific delivery of siRNA targeting SOCS1 enhances HIV-gag-specific CD8 T cell response | |
Bryant et al. | 223 An animal model for non-hodgkin's lymphoma of the central nervous system (NHL-CNS) | |
Willey | Cellular tropism of human immunodeficiency virus: Receptors and inhibitors | |
Alfano et al. | 196 Monocyte-Dependent and-Independent Modulatory Effects of Vitamin D3 on X4 and R5 HIV-1 Replication in IL-2 Stimulated PBMC | |
Hokello | 236 T-Cell Receptor (TCR) Activation Mediates Efficient and Sustained HIV Transcriptional Elongation and Initiation through Multiple Signal Pathways | |
Bredow | Mechanisms of resistance to antibody-dependent cell-mediated cytotoxicity by human immunodeficiency virus | |
Monaco et al. | 183 Morphogenomic immune responsiveness to preventive/therapeutic vaccines | |
Poonia et al. | 191 Anti-FasL treatment preserves SIV-specific memory and slows progression to AIDS in rhesus macaques | |
Mulenga et al. | 229 Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia | |
Manrique | The humoral immune response to HIV and its effect on virus replication and evolution | |
Leite et al. | 203 Immunosuppression Level In HIV-1-Infected Patients Doesn't Affect the Serological Diagnosis of Hepatitis C Virus | |
Bbosa et al. | 247 The effect of chronic alcohol exposure in HIV/AIDS patients on antiretroviral drugs (Triomune30-AZT/3TC/NVP) in Uganda | |
Garcia-Martinez | 156 Humanized Mouse Models for The In Vivo Analysis of HIV Infection | |
de Noronha | 157 Vpr as a mediator of proteasomal degradation and other functions | |
Gupta et al. | 242 Mycobacterium avium KatG protein (MAV_2753): a putative candidate for the serodiagnosis of MAC disease | |
Shankar | 188 Targeted delivery of antiHIV siRNAs to T cells in vivo |